NASDAQ:AZRX
Delisted
AzurRx BioPharma Inc Stock News
$0.155
-0.0080 (-4.90%)
At Close: Aug 17, 2022
AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today
12:47pm, Tuesday, 21'st Sep 2021
Company to begin trading on Nasdaq under new ticker symbol, “FBWI”, effective September 22 Company to begin trading on Nasdaq under new ticker symbol, “FBWI”, effective September 22
3 Penny Stocks That Top Investors Buying Right Now
09:20am, Wednesday, 15'th Sep 2021
Which penny stocks are you watching in September 2021? Here's three for some watchlist inspiration The post 3 Penny Stocks That Top Investors Buying Right Now appeared first on Penny Stocks to Buy, Pi
AzurRx (AZRX) Announces First Wave Bio Acquisition for $229M
12:59pm, Tuesday, 14'th Sep 2021
AzurRx BioPharma (AZRX) acquires First Wave Bio for $229 million. Following the acquisition, the company is set to rename itself as First Wave BioPharma.
BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in
AzurRx BioPharma, Inc. (AZRX) CEO James Sapirstein on First Wave Bio Acquisition - Conference Call Transcript
04:40pm, Monday, 13'th Sep 2021
AzurRx BioPharma, Inc. (AZRX) CEO James Sapirstein on First Wave Bio Acquisition - Conference Call Transcript
AzurRx BioPharma Announces Reverse Merger With First Wave Bio
09:19am, Monday, 13'th Sep 2021
AzurRx BioPharma Inc (NASDAQ: AZRX) has agreed to acquire First Wave Bio Inc in a stock and cash transaction valued at $229 million, including milestone payments. First Wave Bio is a clinical-st
AzurRx BioPharma to be renamed “First Wave BioPharma” and trade under new NASDAQ ticker symbol, “FWBI”
AzurRx BioPharma Announces Reverse Stock Split
12:45pm, Friday, 10'th Sep 2021
Common Stock Will Begin Trading on Split-Adjusted Basis on September 13, 2021 Common Stock Will Begin Trading on Split-Adjusted Basis on September 13, 2021
Phase 2 placebo-controlled clinical trial to confirm safety of FW-1022 and investigate its ability to remove SARS-CoV-2 virus from the GI tract Phase 2 placebo-controlled clinical trial to confirm saf
Review of Interim Safety Data Concluded with Favorable Recommendation to Continue RESERVOIR Trial as Planned
Proposed Phase 1b/2a clinical trial designed to determine safety and potential efficacy of oral and topical FW-420 Proposed Phase 1b/2a clinical trial designed to determine safety and potential effica
AzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference
04:30pm, Tuesday, 07'th Sep 2021
BOCA RATON, Fla., Sept. 07, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemic the
3 Penny Stocks That Top Investors Are Buying Right Now
10:04am, Wednesday, 25'th Aug 2021
Top traders are watching these penny stocks right now, here's why The post 3 Penny Stocks That Top Investors Are Buying Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | P
AzurRx (AZRX) Pancreatic Insufficiency Study Meets Endpoints
12:16pm, Thursday, 19'th Aug 2021
AzurRx (AZRX) is developing lead pipeline candidate as monotherapy and in combination regimen as potential treatment for exocrine pancreatic insufficiency in patients with cystic fibrosis.
AZRX Stock: The Huge Trial News Lifting Little-Known AzurRX BioPharma Today
01:34pm, Wednesday, 18'th Aug 2021
Today, AZRX stock is making headlines after the company showed some impressive results from a clinical trial of a cystic fibrosis treatment. The post AZRX Stock: The Huge Trial News Lifting Little-Kno